After receiving a nebulizer treatment with a beta agonist, the patient complains of feeling slightly nervous and wonders if her asthma is getting worse. What is the nurse's best response?

A. “I will notify the physician about this adverse effect.” Although it is appropriate to report concerning or worsening symptoms, slight nervousness after a beta-agonist nebulizer is a transient and expected effect. Immediate notification isn't necessary unless symptoms escalate. B. "This is an expected adverse effect. Let me take your pulse." Beta-agonists like albuterol can stimulate the sympathetic nervous system, leading to mild side effects such as nervousness, jitteriness, or increased heart rate. This response reassures the patient while also ensuring safety through pulse monitoring. C. "We will hold the treatment for 24 hours." Holding treatment may deprive the patient of necessary bronchodilation during an acute phase of asthma. A slight nervous sensation does not warrant stopping treatment unless accompanied by more severe reactions. D. "The next scheduled nebulizer treatment will be skipped." Skipping a dose without reassessing the patient or provider input may risk worsening asthma control. Minor side effects should be monitored, not cause immediate cancellation of scheduled therapy.